Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 13, 2026
Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Why Is Red Cat Holdings (RCAT) Stock Down -13% Today?

Key Takeaways

  • RCAT shares are falling approximately 13% in premarket trading on May 13, 2026, following the announcement of a $200 million stock offering that threatens significant shareholder dilution
  • The equity offering is the primary catalyst, unveiled before the market open and immediately pressuring the stock
  • A recent Q1 2026 earnings report (released May 7) added an overhang: revenue of $15.5 million missed the FactSet consensus estimate of $17.6 million, and EPS of -$0.22 badly missed the -$0.12 estimate
  • Despite record 849% year-over-year revenue growth driven by U.S. Army drone contracts, profitability and margin concerns remain front and center for investors
  • Shares had already closed Tuesday at $11.03, down nearly 2% on the day, suggesting the stock was under pressure even before the offering news broke
  • Traders are watching the size and pricing of the offering, any use-of-proceeds disclosures, and whether institutional demand is sufficient to absorb the new shares

Opening Summary

Red Cat Holdings (RCAT) is a Puerto Rico-based aerospace and defense company that designs and manufactures tactical drone systems — including its flagship Black Widow small unmanned aerial system (sUAS) — for the U.S. military, NATO allies, and government security agencies. Shares are tumbling roughly 13% in premarket trading on May 13, 2026, declining from Tuesday's closing price of $11.03 to approximately $9.60. The selloff is driven by the company's announcement of a $200 million stock offering, a capital raise that markets are pricing as a dilutive event for existing shareholders at a time when the stock's recent earnings report had already disappointed expectations.

$200 Million Stock Offering Triggers Dilution Selloff

The dominant catalyst for the sharp premarket decline is Red Cat's announcement of a $200 million equity offering, disclosed before Wednesday's opening bell. Stock offerings of this scale are routinely met with selling pressure because they increase the total share count outstanding, diluting the ownership percentage and earnings per share attributable to current investors. The size of the raise is especially notable given the company's current market capitalization, making the dilution particularly pronounced relative to its existing equity base. Investors are reacting by selling ahead of the pricing of the deal, a classic pattern in secondary offerings from smaller-cap growth companies in the defense technology space.

Earnings Miss Adds to the Bearish Backdrop

The offering announcement lands against an already uncertain earnings backdrop. On May 7, 2026, Red Cat reported Q1 fiscal 2026 results that showed $15.5 million in revenue — a record quarter and an extraordinary 849% jump year-over-year, fueled by scaled deliveries under the U.S. Army Short Range Reconnaissance (SRR) program — but still fell short of the FactSet consensus estimate of $17.6 million. The EPS miss was even more severe: the company posted a loss of $0.22 per share, compared to analyst expectations of a $0.10 loss, as operating expenses surged 152% to $29.3 million, driven by sharp increases in R&D, sales and marketing, and G&A costs. Free cash outflow of $31.9 million and a cash balance declining from $167.9 million to $131.9 million during the quarter also flagged burn rate concerns heading into the offering announcement.

Sector Momentum and Contract Win Context

Red Cat has been building an impressive contract portfolio. The company recently won a deal to deliver 173 Black Widow drone systems to Japan's Ministry of Defense, secured new orders from a NATO ally facilitated through the NATO Support and Procurement Agency, and completed the acquisition of swarm robotics firm Apium. These developments speak to strong demand for its defense drone platforms and alignment with the broader global defense spending supercycle. The drone sector has been a market darling on the back of escalating geopolitical tensions and increased government procurement budgets, with defense-focused peers posting outsized gains. However, the stock's ongoing net losses — net loss widened to $26.6 million in Q1 — and the now-confirmed capital raise suggest the growth is coming at a steep cost that the market is increasingly scrutinizing.

Market Context and Trading Activity

Premarket volume in RCAT has already surged significantly relative to its 30-day average premarket volume of approximately 394,000 shares, with over 379,000 shares having changed hands in early premarket hours — an elevated figure consistent with a major corporate event. The stock closed Tuesday at $11.03, itself off 1.96% from the prior session, indicating that selling pressure was building even before the offering news went public. The broader defense ETF space, including names like ITA, will be worth watching during the regular session to assess whether RCAT's move reflects company-specific concerns or a wider sector-level de-risking. The stock's year-to-date gain of approximately 39% heading into Wednesday's session means longer-term holders are still sitting on meaningful profits, which may accelerate selling as they lock in gains into the dilutive offering.

Trending AI Robots

For traders navigating high-volatility events like secondary offerings or earnings reactions in stocks such as RCAT, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers across multiple asset classes, timeframes, and strategies — but only the strongest performers based on current market dynamics are featured in this dedicated Trending section. Each bot is characterized by its traded symbols, risk profile, holding period, and transparent performance metrics, giving traders a clear basis for comparison. Whether you are managing short-term swing trades or seeking systematic exposure to defense and technology trends, exploring the Trending AI Robots page is a sound starting point for integrating data-driven automation into your strategy.

What Comes Next for RCAT

The immediate priority for investors will be the final pricing and terms of the $200 million offering, including the disclosed use of proceeds — whether it targets acquisitions, working capital, SRR program scale-up, or further M&A in the drone ecosystem. Red Cat's next quarterly earnings report is expected around August 24, 2026, where analysts will be watching whether revenue growth is accelerating toward the upper end of contract delivery schedules and whether operating leverage begins to materialize. Contract execution risk remains high: the SRR program has been the engine of growth, and any delivery delays — as seen in prior quarters — could reset investor expectations sharply. Analyst consensus remains constructive, with an average price target of $21.75 from four analysts, though that target will almost certainly be revised following the dilutive offering. Key risks include ongoing net losses, geopolitical disruptions to NATO procurement timelines, integration execution for recently acquired Apium, and competitive pressure from larger defense primes entering the tactical drone market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: RCAT

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


RCAT in downward trend: 10-day moving average broke below 50-day moving average on September 02, 2026

The 10-day moving average for RCAT crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RCAT turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 35 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for RCAT entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.107) is normal, around the industry mean (6.305). P/E Ratio (0.730) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.330).

The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.94B. The market cap for tickers in the group ranges from 4.49 to 1.92T. SPCX holds the highest valuation in this group at 1.92T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -2%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -14%. SAIQ experienced the highest price growth at 153%, while MRLN experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -18%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 71
Price Growth Rating: 66
SMR Rating: 78
Profit Risk Rating: 77
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
RCAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
2800 South West Temple
Phone
+1 800 466-9152
Employees
244
Web
https://www.redcat.red
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.